Permeability enhancers can affect absorption of paracellularly transported drugs. This study aims to evaluate effects of permeability enhancers (chitosan, methyl-β-cyclodextrin, sodium caprate, sodium lauryl sulfate) on the permeability of paracellularly absorbed furosemide and metformin hydrochloride. Methyl thiazole tetrazolium bromide test was carried out to determine the drug concentrations in permeability study. Trans-epithelial Electrical Resistance values determined to assess the integrity of tight junctions. Permeability enhancers were applied at different concentrations alone, in dual/triple combinations. Permeability was determined using human colorectal adenocarcinoma (Caco-2) cells (TEER>400 ohm.cm<sup>2</sup>). Permeability enhancers have no significant effect (<2-fold; p>0.05) on the permeability of furosemide (1.80x10<sup>-5</sup>±4.55x10<sup>-7</sup> cm/s), however metformin permeability (1.36x10<sup>-5</sup>±1.25x10<sup>-6</sup> cm/s) increased significantly (p<0.05) with 0.3%,0.5% (w/v) chitosan (2.0, 2.7-fold, respectively), 1% methyl-β-cyclodextrin (3.5-fold), 10 and 20 µM sodium caprate (2.2, 2.8-fold, respectively), and 0.012% sodium lauryl sulfate (1.9-fold). Furosemide permeability increased significantly (p<0.05) with chitosan-sodium lauryl sulfate combination (1.7-fold), and all triple combinations (1.4-1.9-fold). Chitosan containing dual/triple combinations resulted significant increase (p<0.05) in metformin permeability (1.7-2.8-fold). All results indicated that absorption of furosemide and metformin can be improved by the combination permeability enhancers. Therefore, it can be evaluated for formulation development strategies containing furosemide and metformin by pharmaceutical industry.